Santoyo-Sánchez Mitzi Paola, Pedraza-Chaverri José, Molina-Jijón Eduardo, Arreola-Mendoza Laura, Rodríguez-Muñoz Rafael, Barbier Olivier Christophe
Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City, México.
BMC Nephrol. 2013 Oct 5;14:211. doi: 10.1186/1471-2369-14-211.
Chronic exposure to low cadmium (Cd) levels produces urinary excretion of low molecular weight proteins, which is considered the critical effect of Cd exposure. However, the mechanisms involved in Cd-induced proteinuria are not entirely clear. Therefore, the present study was designed to evaluate the possible role of megalin and cubilin (important endocytic receptors in proximal tubule cells) and angiotensin II type 1 (AT1) receptor on Cd-induced microalbuminuria.
Four groups of female Wistar rats were studied. Control (CT) group, vehicle-treated rats; LOS group, rats treated with losartan (an AT1 antagonist) from weeks 5 to 8 (10 mg/kg/day by gavage); Cd group, rats subchronically exposed to Cd (3 mg/kg/day by gavage) during 8 weeks, and Cd + LOS group, rats treated with Cd for 8 weeks and LOS from weeks 5-8. Kidney Cd content, glomerular function (evaluated by creatinine clearance and plasma creatinine), kidney injury and tubular function (evaluated by Kim-1 expression, urinary excretion of N-acetyl-β-D-glucosaminidase (NAG) and glucose, and microalbuminuria), oxidative stress (measured by lipid peroxidation and NAD(P)H oxidase activity), mRNA levels of megalin, expressions of megalin and cubilin (by confocal microscopy) and AT1 receptor (by Western blot), were measured in the different experimental groups. Data were analyzed by one-way ANOVA or Kruskal-Wallis test using GraphPad Prism 5 software (Version 5.00). P < 0.05 was considered statistically significant.
Administration of Cd (Cd and Cd + LOS groups) increased renal Cd content. LOS-treatment decreased Cd-induced microalbuminuria without changes in: plasma creatinine, creatinine clearance, urinary NAG and glucose, oxidative stress, mRNA levels of megalin and cubilin, neither protein expression of megalin nor AT1 receptor, in the different experimental groups studied. However, Cd exposure did induce the expression of the tubular injury marker Kim-1 and decreased cubilin protein levels in proximal tubule cells whereas LOS-treatment restored cubilin levels and suppressed Kim-1 expression.
LOS treatment decreased microalbuminuria induced by Cd apparently through a cubilin receptor-dependent mechanism but independent of megalin.
长期暴露于低镉(Cd)水平会导致低分子量蛋白质的尿排泄,这被认为是镉暴露的关键效应。然而,镉诱导蛋白尿的机制尚不完全清楚。因此,本研究旨在评估巨膜蛋白和立方蛋白(近端小管细胞中的重要内吞受体)以及血管紧张素II 1型(AT1)受体在镉诱导的微量白蛋白尿中的可能作用。
对四组雌性Wistar大鼠进行研究。对照组(CT),给予溶剂处理的大鼠;LOS组,从第5周开始至第8周用氯沙坦(一种AT1拮抗剂)处理的大鼠(经口灌胃,剂量为10mg/kg/天);Cd组,在8周内亚慢性暴露于镉的大鼠(经口灌胃,剂量为3mg/kg/天),以及Cd + LOS组,用镉处理8周且从第5 - 8周用氯沙坦处理的大鼠。测量不同实验组的肾脏镉含量、肾小球功能(通过肌酐清除率和血浆肌酐评估)、肾损伤和肾小管功能(通过Kim-1表达、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)和葡萄糖的尿排泄以及微量白蛋白尿评估)、氧化应激(通过脂质过氧化和NAD(P)H氧化酶活性测量)、巨膜蛋白的mRNA水平、巨膜蛋白和立方蛋白的表达(通过共聚焦显微镜)以及AT1受体(通过蛋白质免疫印迹法)。使用GraphPad Prism 5软件(版本5.00)通过单因素方差分析或Kruskal-Wallis检验对数据进行分析。P < 0.05被认为具有统计学意义。
给予镉(Cd组和Cd + LOS组)会增加肾脏镉含量。在研究的不同实验组中,氯沙坦处理可降低镉诱导的微量白蛋白尿,而血浆肌酐、肌酐清除率、尿NAG和葡萄糖、氧化应激、巨膜蛋白和立方蛋白的mRNA水平、巨膜蛋白的蛋白质表达以及AT1受体均无变化。然而,镉暴露确实诱导了肾小管损伤标志物Kim-1的表达,并降低了近端小管细胞中立方蛋白的水平,而氯沙坦处理可恢复立方蛋白水平并抑制Kim-1表达。
氯沙坦处理明显通过一种依赖立方蛋白受体但不依赖巨膜蛋白的机制降低了镉诱导的微量白蛋白尿。